Midazolam and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Midazolam (midazolam), especially for people who are male, 40-49 old, also take Epinephrine, and have Cardiac arrest.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Midazolam. It is created by eHealthMe based on reports of 11,245 people who have side effects when taking Midazolam from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,129 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

On Jul, 26, 2026

11,245 people reported to have side effects when taking Midazolam.
Among them, 12 people (0.11%) have Common peroneal nerve dysfunction.

Could Midazolam cause Common peroneal nerve dysfunction?

Among these 12 people:

What is the gender of people who have Common peroneal nerve dysfunction when taking Midazolam? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Common peroneal nerve dysfunction when taking Midazolam? *

What are other drugs people take besides Midazolam? *

Epinephrine: 9 people, 75.00%
Lidocaine: 5 people, 41.67%
Lidocaine Hydrochloride: 3 people, 25.00%
Valproic Acid: 2 people, 16.67%
Cytarabine: 2 people, 16.67%
Dexamethasone: 2 people, 16.67%
Levetiracetam: 2 people, 16.67%
Lorazepam: 2 people, 16.67%
Methotrexate: 2 people, 16.67%
Prednisone: 2 people, 16.67%

What are other side effects people have besides Common peroneal nerve dysfunction? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 16.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 16.67%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 16.67%
Wound Dehiscence (a surgical incision reopens either internally or externally): 1 person, 8.33%
Weakness: 1 person, 8.33%
Thoracic Vertebral Fracture: 1 person, 8.33%
Osteomyelitis (infection of bone): 1 person, 8.33%
Neuropathy Peripheral (surface nerve damage): 1 person, 8.33%
Intervertebral Disc Protrusion (spinal disc protrusion): 1 person, 8.33%
Inappropriate Antidiuretic Hormone Secretion: 1 person, 8.33%

What are the existing conditions these people have? *

Cardiac Arrest: 9 people, 75.00%
Local Anaesthesia: 5 people, 41.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 16.67%
Depression: 2 people, 16.67%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 1 person, 8.33%
Sedation: 1 person, 8.33%
Inflammation: 1 person, 8.33%
Central Nervous System Inflammation (infection of brain or spinal cord): 1 person, 8.33%
B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 8.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midazolam:

Midazolam (11,246 reports)

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (651 drugs)

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (1,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on midazolam (the active ingredients of Midazolam) and Midazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.